Biopharmaceutical / Biotechnology Innovator.
Building Global Industry Partnerships.
INNOVATIVE DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
Leading Biopharmaceutical / Biotechnology Innovator
Vyripharm® is a global biopharmaceutical/biotechnology leader integrating traditional and alternative medicine to improve clinical and patient outcomes.
BIOSYNC TECHNOLOGY
Our BioSync™ Platform
The BioSync Platform™ is the first and only platform that integrates Agri-biopharmaceuticals / Biotechnology and Biopharmaceutical / Biotechnology data acquisition and management.
It also combines advanced data procurement and evaluation from Agri-biopharmaceutical / to Biopharmaceuticals / Biotechnology creating the most robust and innovative data management platform in the world.
WITH ALTERNATIVE MEDICINE
Theranotics combines diagnostics and therapeutics providing a transition from traditional medicine to personalized, patient-centered medicine.
IN THE NEWS:
Vyripharm International, Inc. and the National Yang-Ming University Signed a MOU to Develop VYR-206 as a Novel Diagnostic Approach for Neurological Disorders Outcomes Following Treatments.
Vyripharm Biopharmaceuticals and Regis Technologies, Inc. Have Signed Off on a Master Drug Program Agreement for Expediting cGMP Manufacture of Our Antiviral Agents for Diagnostic Evaluation of COVID-19.
Vyripharm Biopharmaceuticals Is in the Development Stage of a Novel Integrated Theranostic Approach for the Treatment of Viral Infections Such as COVID-19.
We are a global biopharmaceutical and biotechnology leader integrating traditional and alternative medicine.
We design innovative diagnostic and therapeutic applications. Our technologies advance personalized care and precision medicine utilizing data analytics and artificial intelligence.
Vision
Helping people live better lives by providing
Standardization for Public Health and Public Safety.
Mission
The integration of traditional medicine with alternative medicine.
FEATURED HIGHLIGHT
Increased Oversight of the Cannabinoid Industry Reduces the
Risk to Public Health and Safety.
– Eddie Patton Jr., M.D.
CMO Vyripharm Enterprises
Vyripharm Enterprises, Inc. is headquartered in the world-renown Texas Medical Center located in Houston, Texas.
